Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
Werewolf Therapeutics GAAP EPS of -$0.28 Beats by $0.01
Werewolf Therapeutics Q1 EPS $(0.28), Inline
Werewolf Therapeutics | 10-Q: Q1 2026 Earnings Report
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Express News | Werewolf Therapeutics Q1 Operating Income USD -13.271 Million
Express News | Werewolf Therapeutics Q1 Operating Expenses USD 13.271 Million